Delphine Imbert
Corporate Officer/Principal chez CHINOOK THERAPEUTICS, INC.
Profil
Delphine Imbert is currently a member of The American Academy of Political & Social Science and Senior Vice President-CMC & Technical Operations at Chinook Therapeutics, Inc. Previously, she held positions as Principal at ALZA Corp.
and Cellegy Pharmaceuticals, Inc., VP-Pharmaceutical Research & Development at Anacor Pharmaceuticals LLC, and Senior Vice President-Pharmaceutical Sciences at Dermira, Inc. Imbert earned a doctorate degree from the University of Cincinnati (Ohio) and a graduate degree from École Supérieure de Physique et de Chimie de Paris.
Postes actifs de Delphine Imbert
| Sociétés | Poste | Début |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 07/06/2021 |
| The American Academy of Political & Social Science | Corporate Officer/Principal | - |
Anciens postes connus de Delphine Imbert
| Sociétés | Poste | Fin |
|---|---|---|
Cellegy Pharmaceuticals, Inc.
 Cellegy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cellegy Pharmaceuticals specialty biopharmaceutical company, that is primarily engaged in the development and commercialization of prescription drugs targeting women’s health care, including reduction in transmission of HIV and female sexual dysfunction, and gastrointestinal conditions using proprietary topical formulations and nitric oxide, or NO, donor technologies | Corporate Officer/Principal | - |
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | - |
| ALZA CORPORATION | Corporate Officer/Principal | - |
| DERMIRA, INC. | Corporate Officer/Principal | - |
Formation de Delphine Imbert
| University of Cincinnati (Ohio) | Doctorate Degree |
| École Supérieure de Physique et de Chimie de Paris | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Cellegy Pharmaceuticals, Inc.
Cellegy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cellegy Pharmaceuticals specialty biopharmaceutical company, that is primarily engaged in the development and commercialization of prescription drugs targeting women’s health care, including reduction in transmission of HIV and female sexual dysfunction, and gastrointestinal conditions using proprietary topical formulations and nitric oxide, or NO, donor technologies | Health Technology |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
| The American Academy of Political & Social Science | |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
